Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.2543 | 0.2543 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0177 | 1 | 1 |
Echinococcus granulosus | Solute carrier organic anion transporter family | 0.0056 | 0.2543 | 0.1903 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0068 | 0.326 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0173 | 0.9791 | 0.9773 |
Brugia malayi | Kazal-type serine protease inhibitor domain containing protein | 0.0038 | 0.1447 | 0.1447 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.1447 | 0.1447 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0068 | 0.326 | 1 |
Onchocerca volvulus | Putative organic anion transporter | 0.0056 | 0.2543 | 1 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.0177 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.2543 | 0.2543 |
Mycobacterium ulcerans | hypothetical protein | 0.0024 | 0.0585 | 0.0387 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.1447 | 0.1447 |
Brugia malayi | intermediate filament protein | 0.0028 | 0.0791 | 0.0791 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0206 | 0.0206 |
Brugia malayi | sodium-independent organic anion transporter family protein | 0.0056 | 0.2543 | 0.2543 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0024 | 0.0585 | 0.0387 |
Echinococcus granulosus | follistatin | 0.0038 | 0.1447 | 0.0712 |
Onchocerca volvulus | 0.0056 | 0.2543 | 1 | |
Brugia malayi | AMP-binding enzyme family protein | 0.0024 | 0.0585 | 0.0585 |
Toxoplasma gondii | transporter, major facilitator family protein | 0.0056 | 0.2543 | 0.6046 |
Onchocerca volvulus | Putative organic anion transporter | 0.0056 | 0.2543 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0028 | 0.0791 | 0.0791 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0024 | 0.0585 | 0.0446 |
Brugia malayi | sodium-independent organic anion transporter family protein | 0.0056 | 0.2543 | 0.2543 |
Onchocerca volvulus | 0.0028 | 0.0791 | 0.1051 | |
Brugia malayi | hypothetical protein | 0.0056 | 0.2543 | 0.2543 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 0.0177 | 1 | 1 |
Loa Loa (eye worm) | agrin synaptic family protein | 0.0038 | 0.1447 | 0.1447 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0585 | 0.0387 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0585 | 0.0585 |
Echinococcus granulosus | agrin | 0.0038 | 0.1447 | 0.0712 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0068 | 0.326 | 1 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0177 | 1 | 1 |
Brugia malayi | Dihydrofolate reductase | 0.0177 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0206 | 0.0206 |
Onchocerca volvulus | 0.0038 | 0.1447 | 0.4401 | |
Schistosoma mansoni | agrin | 0.0038 | 0.1447 | 0.0712 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0206 | 0.0206 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.076 | 0.076 |
Onchocerca volvulus | 0.0056 | 0.2543 | 1 | |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0024 | 0.0585 | 0.0446 |
Echinococcus multilocularis | agrin | 0.0038 | 0.1447 | 0.0712 |
Echinococcus granulosus | organic anion transporting polypeptide 30B | 0.0056 | 0.2543 | 0.1903 |
Loa Loa (eye worm) | kazal-type serine protease inhibitor domain-containing protein | 0.0038 | 0.1447 | 0.1447 |
Brugia malayi | AMP-binding enzyme family protein | 0.0024 | 0.0585 | 0.0585 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0068 | 0.326 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0791 | 0.0791 |
Brugia malayi | AMP-binding enzyme family protein | 0.0024 | 0.0585 | 0.0585 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0024 | 0.0585 | 0.5 |
Brugia malayi | SPARC precursor | 0.0038 | 0.1447 | 0.1447 |
Echinococcus multilocularis | follistatin | 0.0038 | 0.1447 | 0.0712 |
Echinococcus multilocularis | geminin | 0.0173 | 0.9791 | 0.9773 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.2543 | 0.2543 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0028 | 0.0791 | 0.0791 |
Brugia malayi | prostaglandin transporter | 0.0056 | 0.2543 | 0.2543 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0206 | 0.0206 |
Brugia malayi | secreted modular calcium-binding protein 1 | 0.0038 | 0.1447 | 0.1447 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.1447 | 0.1447 |
Schistosoma mansoni | organic anion transporter | 0.0056 | 0.2543 | 0.1903 |
Onchocerca volvulus | 0.0056 | 0.2543 | 1 | |
Onchocerca volvulus | 0.0056 | 0.2543 | 1 | |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0028 | 0.0791 | 0.0791 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.0177 | 1 | 1 |
Echinococcus granulosus | geminin | 0.0173 | 0.9791 | 0.9773 |
Brugia malayi | sodium-independent organic anion transporter family protein | 0.0056 | 0.2543 | 0.2543 |
Brugia malayi | Kazal-type serine protease inhibitor domain containing protein | 0.0038 | 0.1447 | 0.1447 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0177 | 1 | 1 |
Loa Loa (eye worm) | sodium-independent organic anion transporter | 0.0056 | 0.2543 | 0.2543 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0585 | 0.0387 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0024 | 0.0585 | 0.0387 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0024 | 0.0585 | 0.0387 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0024 | 0.0585 | 0.5 |
Schistosoma mansoni | organic anion transporter | 0.0056 | 0.2543 | 0.1903 |
Onchocerca volvulus | 0.0056 | 0.2543 | 1 | |
Brugia malayi | hypothetical protein | 0.0056 | 0.2543 | 0.2543 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0068 | 0.326 | 1 |
Echinococcus multilocularis | organic anion transporting polypeptide 30B | 0.0056 | 0.2543 | 0.1903 |
Echinococcus multilocularis | expressed protein | 0.0038 | 0.1447 | 0.0712 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0206 | 0.0206 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.2543 | 0.2543 |
Onchocerca volvulus | 0.0028 | 0.0791 | 0.1051 | |
Echinococcus granulosus | dihydrofolate reductase | 0.0177 | 1 | 1 |
Echinococcus multilocularis | Solute carrier organic anion transporter family | 0.0056 | 0.2543 | 0.1903 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0585 | 0.0585 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.2543 | 0.2543 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0585 | 0.0585 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0068 | 0.326 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.2543 | 0.2543 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.1447 | 0.1447 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0024 | 0.0585 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0173 | 0.9791 | 0.9773 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0585 | 0.0387 |
Brugia malayi | Kazal-type serine protease inhibitor domain containing protein | 0.0038 | 0.1447 | 0.1447 |
Onchocerca volvulus | Putative organic anion transporter | 0.0056 | 0.2543 | 1 |
Schistosoma mansoni | dihydrofolate reductase | 0.0177 | 1 | 1 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0024 | 0.0585 | 0.0387 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.2543 | 0.2543 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0018 | 0.0206 | 0.0062 |
Brugia malayi | Kazal-type serine protease inhibitor domain containing protein | 0.0038 | 0.1447 | 0.1447 |
Schistosoma mansoni | follistatin | 0.0038 | 0.1447 | 0.0712 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | > 26.5 ug ml-1 | Inhibitory activity against Candida albicans (40 clinical isolates), determined at pH-5.8 | ChEMBL. | 7473549 |
MIC (functional) | > 26.5 ug ml-1 | Inhibitory activity against Candida albicans (40 clinical isolates), determined at pH-5.8 | ChEMBL. | 7473549 |
MIC (functional) | = 28.4 ug ml-1 | Inhibitory activity against Candida. species. (40 clinical isolates), determined at pH-5.8 | ChEMBL. | 7473549 |
MIC (functional) | > 150 ug ml-1 | Inhibitory activity against Candida albicans (40 clinical isolates), determined at pH-7.2 | ChEMBL. | 7473549 |
MIC (functional) | > 150 ug ml-1 | Inhibitory activity against Candida albicans (40 clinical isolates), determined at pH-7.2 | ChEMBL. | 7473549 |
MIC (functional) | > 352.1 ug ml-1 | Inhibitory activity against Candida. species. (40 clinical isolates), determined at pH-7.2 | ChEMBL. | 7473549 |
MIC50 (functional) | = 8 ug ml-1 | 50% inhibitory activity against Candida albicans (40 clinical isolates) determined at pH-5.8 | ChEMBL. | 7473549 |
MIC50 (functional) | = 8 ug ml-1 | 50% inhibitory activity against Candida albicans (40 clinical isolates) determined at pH-5.8 | ChEMBL. | 7473549 |
MIC50 (functional) | = 32 ug ml-1 | Inhibitory activity against Candida .species (40 clinical isolates), determined at pH-5.8 | ChEMBL. | 7473549 |
MIC50 (functional) | = 64 ug ml-1 | 50% inhibitory activity against Candida albicans (40 clinical isolates) determined at pH-7.2 | ChEMBL. | 7473549 |
MIC50 (functional) | = 64 ug ml-1 | 50% inhibitory activity against Candida albicans (40 clinical isolates) determined at pH-7.2 | ChEMBL. | 7473549 |
MIC50 (functional) | > 256 ug ml-1 | 50% inhibitory activity against the Candida. species (40 clinical isolates) was determined at pH-7.2 | ChEMBL. | 7473549 |
MIC90 (functional) | = 128 ug ml-1 | Inhibitory activity against Candida .species (40 clinical isolates), determined at pH-5.8 | ChEMBL. | 7473549 |
MIC90 (functional) | = 256 ug ml-1 | Inhibitory activity against the Candida albicans (40 clinical isolates), determined at pH-7.2 | ChEMBL. | 7473549 |
MIC90 (functional) | > 256 ug ml-1 | 90% inhibitory activity against Candida. species (40 clinical isolates) determined at pH-7.2 | ChEMBL. | 7473549 |
MIC90 (functional) | = 256 ug ml-1 | Inhibitory activity against the Candida albicans (40 clinical isolates), determined at pH-5.8 | ChEMBL. | 7473549 |
MIC90 (functional) | = 256 ug ml-1 | Inhibitory activity against the Candida albicans (40 clinical isolates), determined at pH-7.2 | ChEMBL. | 7473549 |
MIC90 (functional) | = 256 ug ml-1 | Inhibitory activity against the Candida albicans (40 clinical isolates), determined at pH-5.8 | ChEMBL. | 7473549 |
R (functional) | = 0 % | Percent resistance against Candida albicans (40 clinical isolates) at 256 micro g/mL (pH=5.8), activity is expressed as R%. | ChEMBL. | 7473549 |
R (functional) | = 0 % | Resistance against all Candida. species (40 clinical isolates) at 256 micro g/mL (pH=5.8). Activity is expressed as R%. | ChEMBL. | 7473549 |
R (functional) | = 0 % | Percent resistance against Candida albicans (40 clinical isolates) at 256 micro g/mL (pH=5.8), activity is expressed as R%. | ChEMBL. | 7473549 |
R (functional) | = 40 % | Resistance against Candida. albicans (40 clinical isolates) at 256 microg/mL (pH=7.2), activity is expressed as R%. | ChEMBL. | 7473549 |
R (functional) | = 40 % | Resistance against Candida. albicans (40 clinical isolates) at 256 microg/mL (pH=7.2), activity is expressed as R%. | ChEMBL. | 7473549 |
R (functional) | = 60 % | Percent resistance against all Candida. species (40 clinical isolates) at 256 micro g/mL (pH=7.2), activity is expressed as R%. | ChEMBL. | 7473549 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.